Reduce Time to Market With Pre-IND Meetings

Did you know reducing time to market is one of the biggest challenges companies face when seeking FDA approval on their drug development plans and clinical trials?

Olga Carroll, Alira Health’s Vice President, Regulatory, and Prasanna Palle, Senior Associate Regulatory Consultant offer tips to reduce time to market with Pre-IND Meetings.

Download the Pre-IND worksheet to learn more and set up for success.

To learn more about Alira Health’s Regulatory practice, click here.

To connect with Olga Carroll, click here.